A carregar...
Vitamin D, OPG/RANKL, and Inflammation with Alendronate Treatment in HIV-infected Patients with Reduced Bone Mineral Density
OBJECTIVES: To determine the effect of alendronate (ALN) on inflammatory markers and osteoprotegerin (OPG)/receptor activator of nuclear factor-kappaB ligand (RANKL), and to explore the associations of baseline systemic inflammation and vitamin D status on the bone mineral density (BMD) response to...
Na minha lista:
| Publicado no: | HIV Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4715784/ https://ncbi.nlm.nih.gov/pubmed/26177791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12291 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|